Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Aerie and Inovio Among Pharma Stocks Offering High Risk and Even Higher Upside
By Tip Ranks
Apr 11, 2019 10:05 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Participate In The Stifel 2020 Virtual Healthcare Conference
By Business Wire
Nov 10, 2020 7:30 AM EST
PRESS RELEASES
Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial Of AR-15512 (TRPM8 Agonist) Ophthalmic Solution For The Treatment Of Patients With Dry Eye Disease
By Business Wire
Oct 29, 2020 6:30 AM EDT
PRESS RELEASES
Santen And Aerie Conclude Exclusive License Agreement For Rhopressa® And Rocklatan® In Japan And Several Other Asian Countries
By Business Wire
Oct 28, 2020 3:00 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Announce Third Quarter 2020 Financial Results And Host Conference Call On Thursday, November 5, 2020
By Business Wire
Oct 27, 2020 7:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals Announces Acceptance Of Its Investigational New Drug Application For AR-15512 (TRPM8 Agonist) Eye Drop For Dry Eye Disease
By Business Wire
Sep 29, 2020 6:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals Announces Successful Interim 90-Day Topline Data From Its Six-Month Mercury 3 Clinical Trial In Europe
By Business Wire
Sep 24, 2020 6:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Participate In Upcoming Virtual Investor Conferences
By Business Wire
Sep 8, 2020 7:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Announce Second Quarter 2020 Financial Results And Host Conference Call On Thursday, August 6, 2020
By Business Wire
Jul 30, 2020 7:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals Reports Positive Topline Results For AR-1105 (Dexamethasone Intravitreal Implant) Phase 2 Clinical Trial In Patients With Macular Edema Due To Retinal Vein Occlusion
By Business Wire
Jul 27, 2020 6:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals Appoints Peter J. McDonnell, M.D., To The Company's Board Of Directors
By Business Wire
Jun 11, 2020 6:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Present At The Bank Of America Securities 2020 Healthcare Conference
By Business Wire
May 5, 2020 7:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Announce First Quarter 2020 Financial Results And Host Conference Call On Wednesday, May 6, 2020
By Business Wire
Apr 29, 2020 7:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals Provides 2020 Company And Guidance Update Associated With COVID-19
By Business Wire
Apr 9, 2020 4:01 PM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Present At The Needham Virtual Healthcare Conference
By Business Wire
Apr 7, 2020 7:30 AM EDT
PRESS RELEASES
Aerie Pharmaceuticals To Present At The Cowen 40th Annual Healthcare Conference
By Business Wire
Feb 24, 2020 7:30 AM EST
PRESS RELEASES
Aerie Pharmaceuticals Announces Appointment Of Nina Ohara, PharmD, M.B.A, As Director, Marketing And Gregory Jones, CPA, As Director, Tax
By Business Wire
Feb 18, 2020 6:30 AM EST
PRESS RELEASES
Aerie Pharmaceuticals To Announce Fourth Quarter And Full Year 2019 Financial Results And Host Conference Call On Thursday, February 20, 2020
By Business Wire
Feb 13, 2020 7:30 AM EST
PRESS RELEASES
Aerie Pharmaceuticals Announces Appointment Of Michelle Senchyna, Ph.D., As Vice President, Clinical Development And Medical Affairs
By Business Wire
Feb 3, 2020 6:30 AM EST
INVESTING
Aerie and Inovio Among Pharma Stocks Offering High Risk and Even Higher Upside
By Tip Ranks
Apr 11, 2019 10:05 AM EDT
STOCKS
5 'Strong Buy' Stocks From Wall Street's Best-Performing Analysts
By TheStreet Guest Contributor
Jan 18, 2018 11:36 AM EST
HEALTH
Biotech Movers: Immunomedics, Aerie, Exelixis
By Armie Margaret Lee
May 26, 2017 9:33 AM EDT
HEALTH
Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring
By Armie Margaret Lee
May 25, 2017 9:37 AM EDT
INVESTING
Group Stink; Good, the Bad and the Ugly: Doug Kass' Views
By Doug Kass
May 8, 2017 1:00 AM EDT
INVESTING
Twitter, Netflix, MetLife: Doug Kass' Views
By Doug Kass
Mar 27, 2017 1:00 AM EDT
